The justices are considering an effort challenging longstanding case law blocking the state’s ability to probe inflated drug ...
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...
AstraZeneca has paid CSPC Pharmaceutical Group $100 million for a preclinical cardiovascular disease drug candidate. The deal ...